Personalized Drug Combinations for the Treatment of Acute Myeloid Leukemia (AML) Patients

被引：0
|
作者：
Kang, Yunyi [1 ]
Tran, Trish [1 ]
Zhang, Linda [1 ]
Ball, Edward D. [2 ]
Piermarocchi, Carlo [3 ,4 ]
Paternostro, Giovanni [1 ,4 ]
机构：
[1] Sanford Burnham Med Res Inst, La Jolla, CA USA
[2] Moores UCSD Canc Ctr, La Jolla, CA USA
[3] Michigan State Univ, E Lansing, MI 48824 USA
[4] Salgomed Inc, Del Mar, CA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] OUTCOME OF PERSONALIZED THERAPY BASED ON HIGH-THROUGHPUT EX VIVO DRUG SCREENING IN PATIENTS WITH RELAPSED, CHEMOREFRACTORY ACUTE MYELOID LEUKEMIA (AML)
    Kontro, M.
    Pemovska, Tea
    Kulesskiy, E.
    Edgren, H.
    Eldfors, S.
    Elonen, E.
    Karjalainen, R.
    Majumder, M.
    Murumagi, A.
    Parsons, A.
    Aittokallio, T.
    Wennerberg, K.
    Kallioniemi, O.
    Porkka, K.
    HAEMATOLOGICA, 2013, 98 : 19 - 20
  • [22] Drug Repurposing for the Treatment of Acute Myeloid Leukemia
    Andresen, Vibeke
    Gjertsen, Bjorn T.
    FRONTIERS IN MEDICINE, 2017, 4
  • [23] Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly
    Kuendgen, Andrea
    Germing, Ulrich
    CANCER TREATMENT REVIEWS, 2009, 35 (02) : 97 - 120
  • [24] Clofarabine In Search of Combinations for the Treatment of Patients With High-Risk Acute Myeloid Leukemia
    Musto, Pellegrino
    Ferrara, Felicetto
    CANCER, 2008, 113 (08) : 1995 - 1998
  • [25] Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia
    Florence Rabian
    Etienne Lengline
    Delphine Rea
    Current Hematologic Malignancy Reports, 2019, 14 : 492 - 500
  • [26] Chemotherapy Drug Scheduling for the Induction Treatment of Patients With Acute Myeloid Leukemia
    Pefani, E.
    Panoskaltsis, N.
    Mantalaris, A.
    Georgiadis, M. C.
    Pistikopoulos, E. N.
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2014, 61 (07) : 2049 - 2056
  • [27] Treatment of elderly acute myeloid leukemia (AML) patients with the combination of mitoxantrone and cytarabine (MAC).
    Marinakis, T
    Galanopoulos, AG
    Zomas, A
    Michalis, E
    Gortzolidis, G
    Tsakiridou, A
    Xanthopoulos, V
    Theodoropoulos, G
    Goumakou, H
    Georgiakaki, M
    Grigoraki, V
    Anagnostopoulos, NI
    BLOOD, 2005, 106 (11) : 235B - 235B
  • [28] AngioCRIME in Acute Myeloid Leukemia (AML)
    Macintyre, Elizabeth
    HEMASPHERE, 2017, 1 (01):
  • [29] Synergistic drug combinations promote the development of resistance in acute myeloid leukemia
    Mason-Osann, Emily
    Pomeroy, Amy E.
    Palmer, Adam C.
    Mettetal, Jerome T.
    CANCER RESEARCH, 2023, 83 (07)
  • [30] Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia
    Rabian, Florence
    Lengline, Etienne
    Rea, Delphine
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (06) : 492 - 500
12345